We recently demonstrated that the novelcyclized AMP, CD4-PP, isa potent host immunomodulator having strong antibacterial activityin the context of urinary tract infection.4 Considering the high incidence of dermal infections,5 we wished to establish the possible use of CD4-PP for dermatologicalapplication. The gene discussed is CD4; the disease is urinary tract infection.